Pharm (Comp 3) Flashcards
Endogenous opioids
Examples and MOA
Endorphins, Enkephalins, Dynorphins
mu, delta, and kappa reptor agonists
Effects mediated by mu opioid receptor
- Analgesia
- euphoria
- physical dependence
- bradycardia
- GI transit slowing
- respiratory depression
- Modulator of hormone and NT release
Effects mediated by kappa opioid receptor
- spinal analgesia
- miosis
- sedation, psychomimetic effects
- diuresis
- slowed GI
Effects mediated by delta receptor
- Dysphoric effects
- Analgesia
- Modulator of hormone and NT release
Strong agonist opioids
Morphine, methadone,
heroin, meperidine, fentanyl
Partial/mixed opioid agonist
Pentazocine, buprenorphine
Weak opioid agonists
codeine, hydrocodone
Morphine, Hydromorphone, Oxymorphone
MOA and action/use
- Opioid receptor agonist (miu, kappa, and delta)
- Use: Alter mood/anxiolytic, sedation, depress pain reaction
Morphine, Hydromorphone, Oxymorphone
Toxicity
- Respiratory depression, vasodilation
- Nausea/vomiting, constipation, Biliary colic
- Itching, hypotension, bronchoconstriction (H1)
- Miosis
- Increased prolactin release, inhibition of LH release
- Tolerance, withdrawal, physical dependence, addiction
- Increases intracranial pressure
- Not in pregnancy. Meperidine preferred in labor.
Codeine, Hydrocodone
MOA and use
MOA: Weak opioid receptor
agonist; Metabolized to
morphine
Use: Moderate pain treatment, Anti-tussive
Codeine, Hydrocodone
Toxicity
- Nausea, vomiting
- drowsiness, dizziness
- constipation
- Combined with NSAIDs or acetaminophen
- Codeine –> CYP2D6 metabolism. Genetic polymorphisms may increase toxic effects.
Methadone
MOA and Use
- Opioid receptor agonist;
antagonism on NMDA receptor - Use: Avoidance of
the withdrawal reaction in opioid dependence patients - Long t1/2 allows a slow taper
Methadone
toxicity
Accumulates with repeated doses, which can cause respiratory depression.
Meperidine (Demerol)
MOA and use
Opioid receptor agonist; Antimuscarinic effects; Serotonin effects
Use: Like morphine, but less analgesia
- Good in obstetrics: less neonatal respiratory
depression. Inc contractions
Meperidine
Toxicity
- Normeperidine (metabolite) can induce CNS stimulation esp. renal dysfunction pts
- Serotonin syndrome with SSRIs
- Drug interactions with monamine oxidase inhibitors (MAOIs)
- Hyperrexia coma
Fentanyl, Alfentanil, Sufentanil, Remifentanil
MOA and Use
- Opioid receptor agonist
- 100x more potent than morphine
- IV analgesic. Used for extra-anesthetic analgesia.
Fentanyl, Alfentanil, Sufentanil, Remifentanil
Toxicity
Respiratory depression
Available as transdermal (patch) and transmucosal (lozenge) formulations.
Heroin/Diacetylmorphine
MOA and Use
- Opioid receptor agonist
- Semisynthetic is
metabolized to morphine for action. - Lipid soluble and crosses blood brain barrier quickly
Heroin/Diacetylmorphine
Toxicity
- Super CNS action
- analgesia
- Euphoria
- dependence and addiction
- Illicit use only
Tramadol
MOA and Use
- Mu receptor agonist. NE and 5-HT reuptake inhibitor.
- Weak analgesic, neuropathy
Little opioid toxicities. - High bioavailability, active metabolite.
Tramadol
Toxicity
- May cause hypertensive crisis with MAOI
- Often combined with acetaminophen (added liver toxicity)
Diphenoxylate, Loperamide
MOA
- Weak mu or kappa agonists
- Antidiarrheal
Diphenoxylate, Loperamide
- Diphenoxylate –> combined with atropine to reduce abuse potential
- Loperamide –> no CNS effects, does not cross BBB (Imodium, OTC use)
Opioid drug interactions
CNS depression with:
- ethanol
- antipsychotics
- tricyclic antidepressants
- sedative-hypnotics (eg. benzos)
- antihistamines